The Food and Drug Administration issued an “early alert” concerning FreeStyle Libre 3 and FreeStyle Libre Plus sensors used by people who have diabetes. The agency said Abbott Diabetes Care has sent a ...

Malfunctioning glucose trackers made by Abbott Diabetes Care have been linked to more than 700 severe adverse events and seven potential deaths, the Food and Drug Administration (FDA) and Abbott said.

Misinformation about diabetes can lead to delayed diagnoses, ineffective treatment strategies, and increased health risks. By addressing and dispelling these myths, individuals can make informed ...

Abbott has launched the FreeStyle Libre 2 Plus in India, a state-of-the-art continuous glucose monitoring system providing real-time readings and alerts for diabetics. This innovative device aims to ...

Gestational diabetes (GD) is diabetes that can occur during pregnancy. Individuals with GD may benefit from wearing a device called a continuous glucose monitor (CGM), which monitors blood sugar ...

MISSISSAUGA, ON, Dec. 17, 2024 /CNW/ -- Abbott (NYSE: ABT) today announced that the Government of Alberta has added Abbott's FreeStyle Libre 2 * flash glucose monitoring system to the Alberta Drug ...

Maintaining a healthy blood sugar range is crucial for competitive athletes, allowing them to optimize their performance and minimize potential health risks. Understanding what constitutes an ideal ...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the Omnipod 5 Automated Insulin ...

ACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced ...

The US Food and Drug Administration (FDA) has cleared the Abbott Libre 2 and 3 continuous glucose monitoring (CGM) sensors for use during most imaging procedures, including MRI under certain ...